Marker

(redirected from prognostic marker)
Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia.

Marker

A slang term for documentation indicating that a debt is owed.
References in periodicals archive ?
Procalcitonin is a valuable prognostic marker in cardiac surgery but not specific for infection.
Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?
Ki67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12155 patients.
Clinical prognostic markers in patients with severe sepsis: a prospective analysis of 139 consecutive cases.
However, patients having -13/13 deletion plus poor prognostic markers, IGH rearrangements and P53 deletion had a shortened median OS.
VEGF-C and VEGF-D expression is correlated with lymphatic vessel density and lymph node metastasis in oral squamous cell carcinoma: Implications for use as a prognostic marker.
YKL-40 levels are also elevated in cancer patients, and results from other studies have suggested that YKL-40 may be a prognostic marker in cancer patients, said Dr.
In other cancers, particularly malignant melanoma, a prominent lymphocytic infiltration is often considered a good prognostic marker.
PHILADELPHIA -- Hypertension appears to predict a more severe course of Guillain-Barre syndrome in children and, because it appears within 24-48 hours of the onset of maximum motor disability, might be a valid prognostic marker for these patients, a small study indicates.
Clarient's specialized expertise in cancer testing and its state-of-the-art anatomic pathology clinical laboratory will provide HDC with the ability to quickly commercialize and make available to doctors and patients our new diagnostic and prognostic marker discoveries.
Reporting in the New England Journal of Medicine, researchers at the prestigious Cleveland Clinic in Ohio found that delayed return of the heart rate to normal the first minute after exercise is an important prognostic marker for assessing the risk of death from heart attack.
MammaPrint, an in vitro diagnostic test performed in a central laboratory using the gene expression profile of breast cancer tissue samples to assess a patients' risk for distant metastasis, is indicated for use by physicians as a prognostic marker only, along with other clinical-pathological factors.